AI MARKET SCANNING

Janux Therapeutics Inc

📅 Next Catalyst: Nov 05, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.20%
MAX GAP RECORD -12.72%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $JANX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
-2.30%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
-0.69%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
-1.59%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+1.67%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-1.46%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+0.16%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+1.12%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.5%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $JANX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗